neobookRx
DrugsLevel 4 LocalisationS2EYOEML

Sulfacetamide

SulphonamideAntibacterial

Indications

Registered South African indications:

  • Infection of the eye and eye socket

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients
  • Hypersensitivity to sulphonamides
  • Penetrating wounds of the cornea
  • Coadministration with agents containing silver salts

Cautions

  • Pregnancy
  • Breastfeeding

Adult dosage

Forms avail. in SA and covered in this monograph: oin

Infection of the eye and eye socket
Stye
Trachoma

  • Topical (oin): Apply small quantity into the inner corner of the affected eye, 3 times daily

For external use only. Doctor consultation required if no improvement has occurred within a few days

Paediatric dosage

Paed. forms avail. in SA and covered in this monograph: oin

Infection of the eye and eye socket
Stye
Trachoma

Younger than 2 months

  • Not established for use

Older than 2 months

  • See adult dosage

Special populations

Pregnancy

  • Caution
  • No animal studies have been performed. There are limited/no data on the extent of systemic absorption following ophthalmic use. Sulfonamides have been associated with kernicterus in infants born to mothers who used systemic sulfonamides during their pregnancy

Breastfeeding

  • Caution; not recommended
  • There are limited/no data on the extent of systemic absorption following ophthalmic use. Sulfonamides have been associated with kernicterus in breastfeeding infants whose mothers are administered with systemic sulfonamides. Breastfeeding is not recommended when administering sulfacetamide to the mother. When considering the use of sulfacetamide in breastfeeding mothers, any benefits of treatment of the mother should outweigh the potential risks to the mother and infant  

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Cardiovascular Disorders

  • Oedema

Skin and Subcutaneous Tissue Disorders

  • Rash

Immune, Blood and Lymphatic System Disorders

  • Hypersensitivity reactions
  • Systemic lupus erythematosus

Sensory Disorders

  • Burning eyes
  • Stinging eyes
  • Conjunctival hyperaemia
  • Conjunctivitis
  • Corneal ulceration
  • Eye irritation

Interactions

Silver preparations

Monitoring

None routine

Mechanism of action

Sulfacetamide is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics. They work by competitively inhibiting bacterial para-aminobenzoic acid, an essential component for bacterial growth.

Dosage forms

  • Eye ointment

Formulation

Eye ointment (per 3.5g) 350mg

  • Lennon-Sulphacetamide (Pharmacare) 

References

1. SAMF_11th Edition_Page 573 2. https://drive.google.com/drive/folders/1qrC0WSHdSHcnDvPhF7MoKYpXGt_nSOgd (06/12/1974_Pharmacare_ Sulphacetamide_eye oint) 3. https://www.drugs.com/pregnancy/sulfacetamide-sodium-ophthalmic.html (as accessed on 1/6/2017) 4. U2D: Sulfacetamide (ophthalmic): Drug information; Uptodate [https://www.uptodate.com/contents/sulfacetamide-ophthalmic-drug-information?search=sulfacetamide&source] 5. NAPOS The Drug Database for Acute Porphyria: S01AB04 Sulfacetamide; Accessed online 10 Feb 2019 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?l=gbr&atc_code=S01AB04] 6. South African Institute for Drug-Free Sport: Lennon-Sulphacetamide; Accessed online 10 Feb 2019 [http://www.drugfreesport.org.za/online-medication-check/] 7. PI - Lennon sulphacetamide eye ointment - Aspen - Date of most recent authorisation - 27 May 1999 - Downloaded on SAHPRA OTC on 04 December 2024 [https://medsinfoportal.sahpra.org.za/pi/766faad01ba233054e14058aa5a9c7be.pdf] **No SPC available

Brands & products

2 products · stale NAPPI snapshot · refreshed 5/29/2026 · 158 days old

dropsGeneric· 1 product

from R6.11/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Covancaine 20ml10 mg20S2R122.13R6.11R54.14716596008

eye ointmentGeneric· 1 product

from R25.23/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Lennon Sulphacetamide Eye Ointment 3.5g350 mg/3.5g3S2R75.69R25.23R38.07767360001
Trade names (1)
  • Lennon-Sulphacetamide

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

NeoHealth® ID 14594 · updated 12/4/2024